CREW; Andrew P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for CREW; Andrew P..The latest application filed is for "tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders".

Company Profile

34.33.63

CREW; Andrew P. - Guilford CT
Crew; Andrew P. - Chester CT
Crew; Andrew P. - Gullford CT
Crew; Andrew P. - N. Babylon NY US
Crew; Andrew P. - North Babylon NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tetrahydronaphthalene And Tetrahydroisoquinoline Derivatives As Estrogen Receptor Degraders App 20220274955 - CREW; Andrew P. ; et al.	2022-09-01
Compounds and methods for the targeted degradation of androgen receptor Grant 11,427,548 - Crew , et al. August 30, 2	2022-08-30
Modulators Of Estrogen Receptor Proteolysis And Associated Methods Of Use App 20220267305 - Crew; Andrew P. ; et al.	2022-08-25
Compounds And Methods For The Targeted Degradation Of Androgen Receptor App 20220259154 - BERLIN; Michael ; et al.	2022-08-18
Modulators of estrogen receptor proteolysis and associated methods of use Grant 11,384,063 - Crew , et al. July 12, 2	2022-07-12
Methods Of Treating Breast Cancer With Tetrahydronaphthalene Derivatives As Estrogen Receptor Degrader App 20220193072 - CHEN; Xin ; et al.	2022-06-23
Compounds and methods for the targeted degradation of androgen receptor Grant 11,352,351 - Jin , et al. June 7, 2	2022-06-07
Alanine-based Modulators Of Proteolysis And Associated Methods Of Use App 20220162163 - Berlin; Michael ; et al.	2022-05-26
Mdm2-based Modulators Of Proteolysis And Associated Methods Of Use App 20220127279 - Crew; Andrew P. ; et al.	2022-04-28
Imide-based Modulators Of Proteolysis And Associated Methods Of Use App 20220089570 - CREW; Andrew P. ; et al.	2022-03-24
Compounds and methods for the targeted degradation of androgen receptor Grant 11,236,051 - Crew , et al. February 1, 2	2022-02-01
Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide Grant 11,191,741 - Crew , et al. December 7, 2	2021-12-07
Compounds and methods for the targeted degradation of rapidly accelerated Fibrosarcoma polypeptides Grant 11,173,211 - Crew , et al. November 16, 2	2021-11-16
Modulators of proteolysis and associated methods of use Grant 11,161,841 - Crew , et al. November 2, 2	2021-11-02
Protein-protein Interaction Inducing Technology App 20210315856 - Crew; Andrew P. ; et al.	2021-10-14
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders Grant 11,104,666 - Crew , et al. August 31, 2	2021-08-31
Egfr Proteolysis Targeting Chimeric Molecules And Associated Methods Of Use App 20210220475 - Crew; Andrew P. ; et al.	2021-07-22
Compounds and methods for the targeted degradation of interleukin-1 receptor- associated kinase 4 polypeptides Grant 11,065,231 - Crew , et al. July 20, 2	2021-07-20
Compounds And Methods For The Targeted Degradation Of Androgen Receptor App 20210196710 - SNYDER; Lawrence B. ; et al.	2021-07-01
Compounds And Methods For The Targeted Degradation Of Bromodomain-containing Proteins App 20210187108 - Qian; Yimin ; et al.	2021-06-24
Compounds And Methods For The Targeted Degradation Of Androgen Receptor App 20210171470 - Crew; Andrew P. ; et al.	2021-06-10
TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE App 20210145832 - Crew; Andrew P. ; et al.	2021-05-20
Tetrahydronaphthalene And Tetrahydroisoquinoline Derivatives As Estrogen Receptor Degraders App 20210139458 - Crew; Andrew P. ; et al.	2021-05-13
EGFR proteolysis targeting chimeric molecules and associated methods of use Grant 10,994,015 - Crew , et al. May 4, 2	2021-05-04
Methods Of Treating Prostate Cancer App 20210113557 - CREW; Andrew P. ; et al.	2021-04-22
Tank-binding kinase-1 PROTACs and associated methods of use Grant 10,946,017 - Crew , et al. March 16, 2	2021-03-16
Methods Of Treating Breast Cancer With Tetrahydronaphthalene Derivatives As Estrogen Receptor Degraders App 20210060008 - CHEN; Xin ; et al.	2021-03-04
Indole Derivatives As Estrogen Receptor Degraders App 20210040081 - Crew; Andrew P. ; et al.	2021-02-11
Compounds And Methods For The Targeted Degradation Of Androgen Receptor App 20210040044 - Crew; Andrew P. ; et al.	2021-02-11
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders Grant 10,899,742 - Crew , et al. January 26, 2	2021-01-26
Compounds And Methods For The Targeted Degradation Of Androgen Receptor App 20210009528 - CREW; Andrew P. ; et al.	2021-01-14
Compounds And Methods For The Enhanced Degradation Of Targeted Proteins App 20200392131 - Crew; Andrew P. ; et al.	2020-12-17
Indole derivatives as estrogen receptor degraders Grant 10,865,202 - Crew , et al. December 15, 2	2020-12-15
Compounds and methods for the targeted degradation of androgen receptor Grant 10,844,021 - Crew , et al. November 24, 2	2020-11-24
Compounds and methods for the targeted degradation of fetal liver kinase polypeptides Grant 10,806,737 - Crew , et al. October 20, 2	2020-10-20
Compounds and methods for the targeted degradation of bromodomain-containing proteins Grant 10,772,962 - Qian , et al. September 15, 2	2020-09-15
Compounds and methods for the enhanced degradation of targeted proteins Grant 10,730,870 - Crew , et al.	2020-08-04
Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides Grant 10,723,717 - Crew , et al.	2020-07-28
Modulators Of Estrogen Receptor Proteolysis And Associated Methods Of Use App 20200199107 - Crew; Andrew P. ; et al.	2020-06-25
Cereblon Ligands And Bifunctional Compounds Comprising The Same App 20200155689 - CREW; ANDREW P. ; et al.	2020-05-21
Cereblon Ligands And Bifunctional Compounds Comprising The Same App 20200155690 - Crew; Andrew P. ; et al.	2020-05-21
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders Grant 10,647,698 - Crew , et al.	2020-05-12
Compounds And Methods For The Targeted Degradation Of Rapidly Accelerated Fibrosarcoma Polypeptides App 20200129627 - CREW; ANDREW P. ; et al.	2020-04-30
Modulators of estrogen receptor proteolysis and associated methods of use Grant 10,604,506 - Crew , et al.	2020-03-31
Compounds And Methods For The Targeted Degradation Of Androgen Receptor App 20200095205 - CREW; Andrew P. ; et al.	2020-03-26
Modulators Of Alpha-synuclein Proteolysis And Associated Methods Of Use App 20200085793 - Crew; Andrew P. ; et al.	2020-03-19
Compounds and methods for the targeted degradation of androgen receptor Grant 10,584,101 - Crew , et al.	2020-03-10
Compounds And Methods For The Targeted Degradation Of Androgen Receptor App 20200055825 - Crew; Andrew P. ; et al.	2020-02-20
Modulators Of Fak Proteolysis And Associated Methods Of Use App 20200038513 - Crews; Craig M. ; et al.	2020-02-06
Brm Targeting Compounds And Associated Methods Of Use App 20200038378 - CREW; ANDREW P. ; et al.	2020-02-06
Modulators Of Proteolysis And Associated Methods Of Use App 20190315732 - Crew; Andrew P. ; et al.	2019-10-17
Brm Targeting Compounds And Associated Methods Of Use App 20190300521 - Crew; Andrew P. ; et al.	2019-10-03
Indole Derivatives As Estrogen Receptor Degraders App 20190233408 - Crew; Andrew P. ; et al.	2019-08-01
TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE App 20190192514 - Crew; Andrew P. ; et al.	2019-06-27
Compounds And Methods For The Targeted Degradation Of Interleukin-1 Receptor-associated Kinase 4 Polypeptides App 20190151295 - Crew; Andrew P. ; et al.	2019-05-23
Modulators Of Proteolysis And Associated Methods Of Use App 20180353501 - Crew; Andrew P. ; et al.	2018-12-13
Compounds And Methods For The Targeted Degradation Of Androgen Receptor App 20180346461 - Crew; Andrew P. ; et al.	2018-12-06
Compounds And Methods For The Targeted Degradation Of Fetal Liver Kinase Polypeptides App 20180256586 - Crew; Andrew P. ; et al.	2018-09-13
Modulators Of Estrogen Receptor Proteolysis And Associated Methods Of Use App 20180237418 - Crew; Andrew P. ; et al.	2018-08-23
Cereblon Ligands And Bifunctional Compounds Comprising The Same App 20180228907 - Crew; Andrew P. ; et al.	2018-08-16
Cereblon Ligands And Bifunctional Compounds Comprising The Same App 20180215731 - Crew; Andrew P. ; et al.	2018-08-02
Egfr Proteolysis Targeting Chimeric Molecules And Associated Methods Of Use App 20180193470 - Crew; Andrew P. ; et al.	2018-07-12
Compounds And Methods For The Targeted Degradation Of Enhancer Of Zeste Homolog 2 Polypeptide App 20180177750 - Crew; Andrew P. ; et al.	2018-06-28
Compounds And Methods For The Targeted Degradation Of Rapidly Accelerated Fibrosarcoma Polypeptides App 20180179183 - Crew; Andrew P. ; et al.	2018-06-28
Tetrahydronaphthalene And Tetrahydroisoquinoline Derivatives As Estrogen Receptor Degraders App 20180155322 - Crew; Andrew P. ; et al.	2018-06-07
TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE App 20180147202 - Crew; Andrew P. ; et al.	2018-05-31
Tau-protein Targeting Protacs And Associated Methods Of Use App 20180125821 - Crew; Andrew P. ; et al.	2018-05-10
Compounds And Methods For The Targeted Degradation Of Androgen Receptor App 20180099940 - Crew; Andrew P. ; et al.	2018-04-12
Indole Derivatives As Estrogen Receptor Degraders App 20180072711 - Crew; Andrew P. ; et al.	2018-03-15
Compounds And Methods For The Targeted Degradation Of Androgen Receptor App 20170327469 - Crew; Andrew P. ; et al.	2017-11-16
Protein-protein Interaction Inducing Technology App 20170281784 - Wang; Jing ; et al.	2017-10-05
Compounds And Methods For The Targeted Degradation Of Bromodomain-containing Proteins App 20170065719 - Qian; Yimin ; et al.	2017-03-09
Alanine-based Modulators Of Proteolysis And Associated Methods Of Use App 20170037004 - Crew; Andrew P. ; et al.	2017-02-09
Mdm2-based Modulators Of Proteolysis And Associated Methods Of Use App 20170008904 - Crew; Andrew P. ; et al.	2017-01-12
Compounds And Methods For The Enhanced Degradation Of Targeted Proteins App 20160272639 - Crew; Andrew P. ; et al.	2016-09-22
Compounds And Methods For The Targeted Degradation Of Androgen Receptor App 20160214972 - Jin; Meizhong ; et al.	2016-07-28
Imide-based Modulators Of Proteolysis And Associated Methods Of Use App 20160058872 - Crew; Andrew P. ; et al.	2016-03-03
Imide-based Modulators Of Proteolysis And Associated Methods Of Use App 20150291562 - Crew; Andrew P. ; et al.	2015-10-15
Macrocyclic kinase inhibitors Grant 9,133,224 - Crew , et al. September 15, 2	2015-09-15
Amino pyrimidine anticancer compounds Grant 9,096,624 - Crew , et al. August 4, 2	2015-08-04
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors Grant 8,735,405 - Arnold , et al. May 27, 2	2014-05-27
Macrocyclic Kinase Inhibitors App 20130261086 - Crew; Andrew P. ; et al.	2013-10-03
Amino Pyrimidine Anticancer Compounds App 20130231306 - CREW; Andrew P. ; et al.	2013-09-05
Substituted imidazopyr- and imidazotri-azines Grant 8,481,733 - Crew , et al. July 9, 2	2013-07-09
Amino pyrimidine anticancer compounds Grant 8,399,433 - Appari , et al. March 19, 2	2013-03-19
7-aminofuropyridine derivatives Grant 8,378,104 - Hornberger , et al. February 19, 2	2013-02-19
7-aminofuropyridine Derivatives App 20120046267 - Hornberger; Keith R. ; et al.	2012-02-23
Amino Pyrimidine Anticancer Compounds App 20110136764 - APPARI; Rama Devi ; et al.	2011-06-09
N-substituted imidazopyridine c-Kit inhibitors Grant 7,767,673 - Castelhano , et al. August 3, 2	2010-08-03
Substituted Imidazopyr- And Imidazotri-azines App 20090286768 - Crew; Andrew P. ; et al.	2009-11-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.